3 February 2016 – Early and accurate laboratory confirmation of malaria with microscopy or rapid diagnostic tests is essential in endemic areas to improve the management of patients with febrile illnesses and to strengthen surveillance based on clinical malaria cases. The reliability of microscopy-based diagnosis of malaria depends on quality management systems in place and optimal use of resources. This manual is designed to assist managers of national malaria programmes and reference laboratories in investing in quality assurance of malaria microscopy. It will be released in French and Spanish soon.
1 February 2016 – UNITAID and IVVC have announced a joint initiative to support African countries in obtaining new and effective insecticides at lower prices. Speaking at the launch event, Dr Pedro Alonso, Director of the WHO Global Malaria Programme, said: “Effective vector control is a cornerstone of our global strategy for malaria. We welcome this joint initiative to accelerate the development and deployment of new insecticides and vector control tools."
WHO issues its first position paper on a malaria vaccine
29 January 2016 – WHO issued today a position paper on RTS,S/AS01, a vaccine that provides partial protection against Plasmodium falciparum, the most deadly malaria parasite globally. RTS,S is the first malaria vaccine to complete pivotal Phase 3 testing and obtain a positive scientific opinion from a stringent medicines regulatory authority. The vaccine is being considered as a complementary malaria control tool in Africa that could potentially be added to – and not replace – the core package of proven malaria preventive, diagnostic and treatment interventions.
15 January 2016 – Rapid scale up of malaria vector control interventions, especially with the use of long-lasting insecticidal nets (LLINs), has contributed significantly to the reduction of malaria cases and deaths in the past 15 years. However, growing resistance to pyrethroid insecticides in malaria vectors could jeopardize these gains. These new recommendations focus on the potential use of LLINs treated with a pyrethroid insecticide and piperonyl butoxide, and on the need to gather more evidence on conditions and settings where they have increased efficacy compared to pyrethroid-only LLINs. These recommendations will be revised periodically, on the basis of emerging evidence.
WHO, FIND and US CDC have released the latest report on malaria RDT product testing. The report provides a comparative measure of RDT performance in a standardized way to distinguish between well and poorly performing tests.
This information note provides an updated list of recommended criteria for selecting rapid diagnostics tests for malaria, and highlights the performance of tests evaluated by the WHO malaria RDT product testing programme.
7 December 2015 – The documents provide guidance on malaria treatment in pregnancy, the role of mass drug administration, and areas or conditions unsuitable for the scale back of malaria vector control activities.
The Department has streamlined the overall design of its printed and electronic publications. This page provides an overview of the main changes.